AKT1 and cancer: Recent studies have reported that several bioactive compounds generated ROS to activate apoptosis signaling in cancer cells, while ROS-dependent suppressing the activity of the PI3K/Akt signaling pathway (Mi et al., 2016; Song et al., 2017; Guo et al., 2018).